← SearchDiscovery of Adjuvants that Direct T-cell Fates for Improved Safety and Efficacy in Vaccines Against Influenza and Tuberculosis$1,989,733N01FY2024AINIHUniversity Of Chicago, Chicago ILInvestigatorsAaron Esser-KahncontactView original record on NIH RePORTER →